You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor regression grade

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oncological Impact of Lateral Nodes in Rectal Cancer

Completed
  • Colorectal Adenocarcinoma
  • Neoadjuvant chemoradiotherapy (CRT)
  • (no location specified)
Oct 20, 2022

DLCS for Predicting Neoadjuvant Chemotherapy Response

Recruiting
  • Gastric Cancer
  • +4 more
  • develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022

Gastric Cancer, Adenocarcinoma of the Stomach Trial in Roma (CT scan)

Recruiting
  • Gastric Cancer
  • Adenocarcinoma of the Stomach
  • CT scan
  • Roma, Italy
    Giovanni Maria Garbarino
May 6, 2021

Low-Grade Squamous Intraepithelial Lesions Trial in Tuzla, Zagreb (DL-alpha lipoic acid, (rice starch))

Completed
  • Low-Grade Squamous Intraepithelial Lesions
  • DL-alpha lipoic acid
  • placebo (rice starch)
  • Tuzla, Bosnia and Herzegovina
  • +1 more
Jul 31, 2022

From Patients With High Grade Gliomas

Recruiting
  • High Grade Glioma
  • Radiotherapy as per standard of care
  • Toronto, Ontario, Canada
    University Health Network
Jun 21, 2023

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Seizure Control asNew Metric in Assessing Efficacy of Tumor

Active, not recruiting
  • Brain Neoplasm
  • +2 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Apr 21, 2022

Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

Not yet recruiting
  • Low Grade Glioma of Brain
  • PEPIDH1M vaccine + vorasidenib
  • Durham, North Carolina
    Duke University Medical Center
Nov 2, 2022

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

    Not yet recruiting
    • High Grade Glioma
    • +3 more
    • Phoenix, Arizona
      St. Joseph's Hospital and Medical Center
    Mar 6, 2023

    pTRG in Rectal Cancer With Establishment of

    Recruiting
    • Rectal Cancer
    • pelvic MRI for establishing new mrTRG method
    • Beijing, Beijing, China
    • +2 more
    May 11, 2022

    Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

    Recruiting
    • Glioma
    • +4 more
    • 18F-Fluciclovine PET-MRI
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Dec 22, 2022

    Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

    Not yet recruiting
    • Low-grade Glioma
    • (no location specified)
    Oct 3, 2022

    High Grade Glioma Trial in Phoenix (BDTX-1535)

    Not yet recruiting
    • High Grade Glioma
    • Phoenix, Arizona
      St. Joseph's Hospital and Medical Center
    Oct 2, 2023

    SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    Recurrent High Grade Glioma Trial (Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
    • (no location specified)
    Jul 21, 2022

    Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)

    Recruiting
    • Brain Tumor
    • Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Oct 6, 2022

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Supramaximal Resection Versus Maximal Resection for High-Grade

    Recruiting
    • Glioblastoma
    • +11 more
    • Supramaximal resection
    • Maximal safe resection
    • San Francisco, California
    • +7 more
    Nov 1, 2023

    The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

    Recruiting
    • Glioblastoma
    • +4 more
    • Tumor resection
    • Tumor biopsy
    • San Francisco, California
    • +7 more
    Nov 18, 2023

    Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

    Recruiting
    • Brain Metastases
    • +3 more
    • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    • Bevacizumab Injection
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 12, 2022

    gastRic Cancer patIentS Undergoing Multimodal trEatment

    Recruiting
    • Gastric Cancer
    • +3 more
    • Observational Survey
    • Lublin, Poland
      Medical University of Lublin
    Feb 9, 2023

    Brain Tumor, Cervical Cancer Trial in Houston (18F-FTX)

    Recruiting
    • Brain Tumor
    • Cervical Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 9, 2022